BC Cancer - Vancouver

600 W 10th Avenue
Vancouver, BC V5Z 4E6

Clinical Trial Unit Manager
Darko Curman
604-877-6000 x673226
dcurman@bccancer.bc.ca

Other

A phase I/II study of CX-5461

Cancer Type
Other
Phase I/II
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date

A Phase II Open Label, Randomized Non-Comparative Trial of Nivolumab Alone or in Combination With Ipilimumab for the Treatment of Patients With Advanced Hypermutated Solid Tumors Detected by a Blood Based Assay

CAPTUR: Canadian Profiling and Targeted Agent Utilization Trial, A Phase II Basket Trial

A Phase 1/2a Study of BMS-986205 Administered in Combination With Nivolumab (BMS-936558, Anti-PD-1 Monoclonal Antibody) in Advanced Malignant Tumors

Cancer Type
Other
Phase I/II
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date

A Phase 1/2a Study of BMS-986253 in Combination With Nivolumab in Advanced Cancers

Cancer Type
Other
Phase I/II
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Dose Expansion Study of NKTR-214 and Nivolumab in Patients With Select Locally Advanced or Metastatic Solid Tumor Malignancies.

Cancer Type
Other
Phase I/II
Recruiting Dates
BC Cancer - Vancouver
Open Recruiting Date

A Randomized, Double Blind, Double-dummy, 2-treatment, 2-period Crossover Comparison of Sennosides and Polyethylene Glycol in Treatment of Opioid-induced Constipation in Outpatients With Cancer

A Phase 1b, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-0482 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced/Metastatic Solid Tumors

CAFCARS: A Randomized, Double-Blind, Placebo-Controlled, Multiple Crossover N-of-1 Study Design of the Use of Medicinal Cannabis Oil-Based Extracts for Symptom Management in Cancer Patients

Cancer Type
Other
Phase II
Recruiting Dates
BC Cancer - Victoria
Open Recruiting Date
BC Cancer - Vancouver
Open Recruiting Date
Back to top